BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Couñago F, Luna J, Guerrero LL, Vaquero B, Guillén-Sacoto MC, González-Merino T, Taboada B, Díaz V, Rubio-Viqueira B, Díaz-Gavela AA, Marcos FJ, del Cerro E. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions. World J Clin Oncol 2019; 10(10): 318-339 [PMID: 31799148 DOI: 10.5306/wjco.v10.i10.318]
URL: https://www.wjgnet.com/2218-4333/full/v10/i10/318.htm
Number Citing Articles
1
David D. Greenberg. CORR Insights®: Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?Clinical Orthopaedics & Related Research 2020; 478(11): 2458 doi: 10.1097/CORR.0000000000001315
2
Doo Yong Chung, Dong Hyuk Kang, Hae Do Jung, Joo Yong Lee, Do Kyung Kim, Jee Soo Ha, Jinhyung Jeon, Kang Su Cho. Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysisInvestigative and Clinical Urology 2023; 64(3): 242 doi: 10.4111/icu.20230058
3
Yi-Hsing Chen, Ue-Cheung Ho, Lu-Ting Kuo. Oligometastatic Disease in Non-Small-Cell Lung Cancer: An UpdateCancers 2022; 14(5): 1350 doi: 10.3390/cancers14051350
4
Dung-Tsa Chen, Wenyaw Chan, Zachary J. Thompson, Ram Thapa, Amer A. Beg, Andreas N. Saltos, Alberto A. Chiappori, Jhanelle E. Gray, Eric B. Haura, Trevor A. Rose, Ben Creelan, Wei Wang. Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancerPLOS ONE 2021; 16(7): e0252041 doi: 10.1371/journal.pone.0252041
5
E. Dansin, F. Le Tinier, L. Brouchet, A. Desmet, C. Massabeau, P. Van Houtte, J. Khalifa. Prise en charge des cancers bronchiques non à petites cellules oligométastatiquesRevue des Maladies Respiratoires Actualités 2020; 12(2): 2S94 doi: 10.1016/S1877-1203(20)30090-2
6
Xabier Mielgo-Rubio, Javier Garde-Noguera, Oscar Juan, Felipe Couñago. Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS studyWorld Journal of Clinical Oncology 2020; 11(12): 983-989 doi: 10.5306/wjco.v11.i12.983
7
C. Faivre-Finn, N. Venissac, B. Besse, E. Dansin, D. Moro-Sibolot. Prise en charge des cancers bronchiques non à petites cellules oligométastatiquesRevue des Maladies Respiratoires Actualités 2021; 13(2): 2S109 doi: 10.1016/S1877-1203(21)00104-X
8
Katsuhiro Hayashi, Hiroyuki Tsuchiya. The role of surgery in the treatment of metastatic bone tumorInternational Journal of Clinical Oncology 2022; 27(8): 1238 doi: 10.1007/s10147-022-02144-6
9
Caleb J. Euhus, Taylor R. Ripley, Cristian G. Medina. The Role of Surgery for Oligometastatic Non-Small Cell Lung CancerCancers 2022; 14(10): 2524 doi: 10.3390/cancers14102524
10
Sankha Bhattacharya. The Incredible Potential of Exosomes as Biomarkers in the Diagnosis of Colorectal CancerCurrent Drug Research Reviews 2022; 14(3): 188 doi: 10.2174/2665998002666220501164429
11
Eunji Choi, Sophia J Luo, Jacqueline V Aredo, Leah M Backhus, Lynne R Wilkens, Chloe C Su, Joel W Neal, Loïc Le Marchand, Iona Cheng, Heather A Wakelee, Summer S Han. The Survival Impact of Second Primary Lung Cancer in Patients With Lung CancerJNCI: Journal of the National Cancer Institute 2022; 114(4): 618 doi: 10.1093/jnci/djab224
12
Abhishek Mahato, Gaurav P.S. Gahlot, Deepak Kumar Jha, Rajhans Rajhans. Inguinal Lymphadenopathy: A Rare Initial Site of Metastatic Lung CarcinomaWorld Journal of Nuclear Medicine 2022; 21(04): 334 doi: 10.1055/s-0042-1750397
13
Huan Ding, Li Shi, Zhuo Chen, Yi Lu, Zhiyu Tian, Hongyu Xiao, Xiaojing Deng, Peiyi Chen, Yue Zhang. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancerBMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01341-6
14
Leilei Wu, Zhenshan Zhang, Menglin Bai, Yujie Yan, Jinming Yu, Yaping Xu. Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientationsCell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01139-8
15
Rong Ma, Qian Zhao, Ren Zhao, Juan Li, Yan-Yang Wang. Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancerNuclear Medicine Communications 2022; 43(9): 1026 doi: 10.1097/MNM.0000000000001599
16
Felipe Renê Alves Oliveira, Allan de Oliveira Santos, Mariana da Cunha Lopes de Lima, Ivan Felizardo Contrera Toro, Thiago Ferreira de Souza, Bárbara Juarez Amorim, Aristoteles Souza Barbeiro, Elba Etchebehere. The ratio between the whole-body and primary tumor burden, measured on 18F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancerRadiologia Brasileira 2021; 54(5): 289 doi: 10.1590/0100-3984.2020.0054
17
Castalia Fernández, Arturo Navarro-Martin, Andrea Bobo, Joaquín Cabrera-Rodriguez, Patricia Calvo, Rodolfo Chicas-Sett, Javier Luna, Nuria Rodríguez de Dios, Felipe Couñago. Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?World Journal of Clinical Oncology 2022; 13(2): 101-115 doi: 10.5306/wjco.v13.i2.101
18
Rodolfo Chicas-Sett, Juan Zafra-Martin, Ignacio Morales-Orue, Juan Castilla-Martinez, Miguel A. Berenguer-Frances, Elisa Gonzalez-Rodriguez, Delvys Rodriguez-Abreu, Felipe Couñago. Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative IntentCancers 2020; 12(8): 2178 doi: 10.3390/cancers12082178
19
Kuo Li, Xiaonian Cao, Bo Ai, Han Xiao, Quanfu Huang, Zheng Zhang, Qian Chu, Li Zhang, Xiaofang Dai, Yongde Liao. Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapyThoracic Cancer 2021; 12(15): 2161 doi: 10.1111/1759-7714.14044
20
Satoshi Kato, Satoru Demura, Ryo Kitagawa, Noriaki Yokogawa, Takaki Shimizu, Motoya Kobayashi, Yohei Yamada, Satoshi Nagatani, Hideki Murakami, Norio Kawahara, Hiroyuki Tsuchiya. Clinical outcomes following total en bloc spondylectomy for spinal metastases from lung cancerJournal of Orthopaedic Science 2023;  doi: 10.1016/j.jos.2023.04.007
21
Mónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, Dolores de la Mata-Moya, Diego Díaz-García, Luis Lara-Mejía, Zyanya Lucia Zatarain-Barrón, María-Fernanda Cuevas-Góngora, Feliciano Barron-Barron, José Francisco Corona-Cruz, Luis Cabrera-Miranda, Marisol Arroyo-Hernández, Raquel Gerson, Oscar Arrieta. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 studyLung Cancer 2021; 152: 119 doi: 10.1016/j.lungcan.2020.12.029
22
Atallah Baydoun, VeAnn L. Lee, Tithi Biswas. Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective TrialsCancers 2022; 14(21): 5339 doi: 10.3390/cancers14215339
23
Javier Garde-Noguera, Margarita Martín-Martín, Andres Obeso, Miriam López-Mata, Inigo Royo Crespo, Lira Pelari-Mici, O Juan Vidal, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes, Felipe Couñago. Current treatment landscape for oligometastatic non-small cell lung cancerWorld Journal of Clinical Oncology 2022; 13(6): 485-495 doi: 10.5306/wjco.v13.i6.485
24
Lukas Käsmann. Advances in Radiation Oncology in Lung CancerMedical Radiology 2022; : 1001 doi: 10.1007/174_2022_339
25
Çağatay Çetinkaya, Hasan Fevzi Batırel. Airway diseases2023; : 1 doi: 10.1007/978-3-031-22483-6_65-1
26
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, Valentino Martelli, Giulia Corrao, Giuseppe Lo Russo, Claudia Proto, Roberto Ferrara, Giulia Galli, Alessandro De Toma, Carlo Genova, Barbara Alicja Jereczek-Fossa, Filippo de Braud, Marina Chiara Garassino, Sara Elena Rebuzzi. Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic ProgressionCancers 2021; 13(6): 1300 doi: 10.3390/cancers13061300
27
Jeong Uk Lim. Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase InhibitorsClinical Lung Cancer 2021; 22(5): e786 doi: 10.1016/j.cllc.2021.03.004
28
Satoshi Kato, Satoru Demura, Kazuya Shinmura, Noriaki Yokogawa, Takaki Shimizu, Hideki Murakami, Norio Kawahara, Katsuro Tomita, Hiroyuki Tsuchiya. Surgical Metastasectomy in the Spine: A Review ArticleThe Oncologist 2021; 26(10): e1833 doi: 10.1002/onco.13840
29
Hae Lin Cho, Tracy Balboni, Sebastian Matthias Christ, Brandon Turner, Alexander Spektor, Subha Perni. Is Oligometastatic Cancer Curable? A Survey of Oncologist Perspectives, Decision Making, and CommunicationAdvances in Radiation Oncology 2023; 8(5): 101221 doi: 10.1016/j.adro.2023.101221
30
Céline Goffinet, H. Marshall, Ian A. Yang, R.V. Bowman, Kwun M. Fong. Encyclopedia of Respiratory Medicine2022; : 785 doi: 10.1016/B978-0-08-102723-3.00049-4
31
François Montagne, Florian Guisier, Nicolas Venissac, Jean-Marc Baste. The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the ArtCancers 2021; 13(15): 3711 doi: 10.3390/cancers13153711
32
Neal Andruska, Hayley B. Stowe, Cathryn Crockett, Wei Liu, David Palma, Corinne Faivre-Finn, Shahed N. Badiyan. Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging ScenariosJournal of Thoracic Oncology 2021; 16(7): 1075 doi: 10.1016/j.jtho.2021.04.002
33
Satoshi Kato, Satoru Demura, Hideki Murakami, Kazuya Shinmura, Noriaki Yokogawa, Ryohei Annen, Motoya Kobayashi, Yohei Yamada, Satoshi Nagatani, Norio Kawahara, Hiroyuki Tsuchiya. Medium to Long-Term Clinical Outcomes of Spinal MetastasectomyCancers 2022; 14(12): 2852 doi: 10.3390/cancers14122852
34
Mihriban Erdoğan, Gönül Demir, Zeliha Güzelöz, Ferhat Eyiler, Cüneyt Ebruli, Olçun Ümit Ünal, Murat Keser, Mustafa Emiroğlu. Radiotherapy in Oligometastatic and Oligoprogressive DiseaseThe Journal of Tepecik Education and Research Hospital 2023; 33(1): 1 doi: 10.4274/terh.galenos.2021.70487